Physician profile
John Michael Mccabe
NPI 1598723660
$3,866.53
in general payments reported to CMS, 2019-2025
19 companies · $358 in 2025
The $358 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $737 · 2020: $858 · 2021: $922 · 2022: $437 · 2023: $317 · 2024: $238 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $913.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $893.08 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $543.79 | 2019-2022 | |
| Abiomed | $444.81 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $357.35 | 2019-2025 | Eliquis, Camzyos |
| Amgen INC. | $301.68 | 2019-2025 | Repatha |
| Janssen Pharmaceuticals, INC | $284.28 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $227.06 | 2019-2024 | Lifevest |
| Boston Scientific Corporation | $170.81 | 2020-2025 | Avvigo Guidance System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.59 | 2019-2025 | Jardiance |
| Vital Connect, INC | $128.60 | 2023-2025 | Vitalpatch Rtm |
| Pfizer INC. | $80.17 | 2019-2025 | |
| Cardiva Medical, INC. | $72.07 | 2021 | |
| Medtronic, INC. | $62.35 | 2024-2025 | Linq II, Onyx Frontier |
| Inari Medical, INC. | $50.67 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novo Nordisk INC | $36.27 | 2025 | Wegovy |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $25.58 | 2022 | |
| Medtronic Vascular, INC. | $24.41 | 2019-2020 | |
| Edwards Lifesciences Corporation | $15.95 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.01 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mccabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.